Evidence map›Paper›PMID 42577080›Full record

ArticleFrontiers in immunology2026

Huiying Li, Pamela V Andrade, Irem Huriye Ceren, Alexis Ruiz, Aline I Silva, Murilo F Farias, Thalles S Zorzeto, Mariz Vainzof, Francesco Zorzato, Helga C A Silva and 1 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Huiying LiDepartment of Biomedicine and Neurology, Basel University Hospital, Basel, Switzerland.
Pamela V AndradeBrazilian Malignant Hyperthermia Unit. Department of Anesthesiology, Pain and Intensive Care, University Federal of São Paulo, São Paulo, Brazil.
Irem Huriye CerenDepartment of Biomedicine and Neurology, Basel University Hospital, Basel, Switzerland.
Alexis RuizDepartment of Biomedicine and Neurology, Basel University Hospital, Basel, Switzerland.
Aline I SilvaBrazilian Malignant Hyperthermia Unit. Department of Anesthesiology, Pain and Intensive Care, University Federal of São Paulo, São Paulo, Brazil.
Murilo F FariasBrazilian Malignant Hyperthermia Unit. Department of Anesthesiology, Pain and Intensive Care, University Federal of São Paulo, São Paulo, Brazil.
Thalles S ZorzetoBrazilian Malignant Hyperthermia Unit. Department of Anesthesiology, Pain and Intensive Care, University Federal of São Paulo, São Paulo, Brazil.
Mariz VainzofHuman Genome and Stem Cells Research Center, Institute of Biosciences, University of São Paulo, São Paulo, Brazil.
Francesco ZorzatoDepartment of Biomedicine and Neurology, Basel University Hospital, Basel, Switzerland.
Helga C A SilvaBrazilian Malignant Hyperthermia Unit. Department of Anesthesiology, Pain and Intensive Care, University Federal of São Paulo, São Paulo, Brazil.
Susan TrevesDepartment of Biomedicine and Neurology, Basel University Hospital, Basel, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ryanodine receptor 1 (RyR1) is a key intracellular Ca

Indexed as

B-LymphocytesGenetic Predisposition to DiseaseMalignant HyperthermiaMutationRyanodine Receptor Calcium Release ChannelAdultCalciumCytokinesFemaleHumansMaleMiddle AgedPhenotypeCalciumCytokinesRyanodine Receptor Calcium Release ChannelRYR1 protein, humanB-lymphocytesCD86 and CD40malignant hyperthermia susceptibilitymutationsryanodine receptor 1surface expression

Identifiers

PMID42577080
PMCPMC13453734

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.